Showing 2,901 - 2,920 results of 18,320 for search 'significantly ((((lower decrease) OR (((a decrease) OR (nn decrease))))) OR (teer decrease))', query time: 0.68s Refine Results
  1. 2901

    Principal coordinates analysis (PCoA). by Wararak Choovanichvong (22110371)

    Published 2025
    “…Analysis of bacterial abundance revealed a shift in trends as the disease combined from control to NSESKD and SESKD group, respectively, across 7 genera: <i><i>Actinobacillus</i></i>, <i>TM7x</i>, <i><i>Capnocytophaga</i></i>, <i><i>Neisseria</i></i>, and <i><i>Leptotrichia</i></i> increased in abundance, while <i><i>Actinomyces</i></i> and <i><i>Atopobium</i></i> decreased. …”
  2. 2902

    Initial participants by wave*. by Yeo Ju Sohn (18536198)

    Published 2024
    “…<div><p>Background</p><p>Diabetes mellitus (DM) is a significant public health concern, particularly in the elderly population. …”
  3. 2903

    General characteristics of research participants. by Yeo Ju Sohn (18536198)

    Published 2024
    “…<div><p>Background</p><p>Diabetes mellitus (DM) is a significant public health concern, particularly in the elderly population. …”
  4. 2904
  5. 2905

    Table2_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.DOCX by Sofia Schaeffer (20379954)

    Published 2024
    “…<p>Metabolic dysfunction–associated steatotic liver disease (MASLD) is a multisystemic disease with a multifactorial pathogenesis involving dietary, environmental, and genetic factors. …”
  6. 2906

    Table1_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.DOCX by Sofia Schaeffer (20379954)

    Published 2024
    “…<p>Metabolic dysfunction–associated steatotic liver disease (MASLD) is a multisystemic disease with a multifactorial pathogenesis involving dietary, environmental, and genetic factors. …”
  7. 2907
  8. 2908
  9. 2909
  10. 2910
  11. 2911
  12. 2912
  13. 2913

    Data. by Aroon La-up (14095691)

    Published 2025
    “…This study found a statistically significant decrease in BMD in the group with the lowest U-Cd levels (<2.0 μg/g creatinine, p = 0.001) and in the overall sample (from 0.392 ± 0.079 μg/g creatinine in 2019 to 0.384 ± 0.094 μg/g creatinine in 2022, p = 0.004). …”
  14. 2914
  15. 2915
  16. 2916
  17. 2917
  18. 2918
  19. 2919
  20. 2920